WallStSmart
LGND

Ligand Pharmaceuticals Incorporated

NASDAQ: LGND · HEALTHCARE · BIOTECHNOLOGY

$224.86
-3.21% today

Updated 2026-04-29

Market cap
$2.73B
P/E ratio
36.74
P/S ratio
10.17x
EPS (TTM)
$6.12
Dividend yield
52W range
$99 – $247
Volume
0.2M

Ligand Pharmaceuticals Incorporated (LGND) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$140.96M$12.89M$27.32M$38.94M$23.54M$30.04M$31.39M$48.97M$64.54M$71.91M$108.97M$141.10M$251.45M$120.28M$163.56M$241.54M$196.25M$131.31M$167.13M$268.09M
Revenue growth (YoY)-90.9%+111.8%+42.6%-39.6%+27.6%+4.5%+56.0%+31.8%+11.4%+51.5%+29.5%+78.2%-52.2%+36.0%+47.7%-18.8%-33.1%+27.3%+60.4%
Cost of revenue$22.64M$58.73M$41.70M$15.23M$6.46M$4.91M$3.60M$5.73M$9.14M$5.81M$5.57M$5.37M$6.34M$11.35M$30.42M$62.18M$52.83M$35.05M$11.07M$6.59M
Gross profit$118.32M$12.89M$27.32M$23.70M$23.54M$25.13M$27.79M$43.24M$55.40M$66.11M$103.40M$135.74M$245.12M$108.94M$133.14M$179.37M$143.42M$96.27M$156.06M$261.50M
Gross margin83.9%100.0%100.0%60.9%100.0%83.7%88.5%88.3%85.8%91.9%94.9%96.2%97.5%90.6%81.4%74.3%73.1%73.3%93.4%97.5%
R&D$41.93M$44.62M$30.77M$39.87M$22.07M$10.29M$10.79M$9.27M$12.12M$13.38M$21.22M$26.89M$27.86M$55.91M$40.50M$32.10M$36.08M$24.54M$21.43M$81.18M
SG&A$248.28M$30.41M$23.79M$30.45M$29.72M$14.98M$16.11M$17.98M$22.57M$24.38M$26.62M$28.65M$37.73M$41.88M$60.01M$46.79M$70.06M$52.79M$78.65M$92.45M
Operating income$-168.77M$-60.17M$-97.28M$-9.97M$-29.30M$-698000.00$574000.00$14.94M$19.63M$27.33M$43.88M$68.08M$163.73M$807.08M$37.50M$103.85M$3.04M$11.94M$-22.61M$47.20M
Operating margin-119.7%-466.7%-356.1%-25.6%-124.5%-2.3%1.8%30.5%30.4%38.0%40.3%48.2%65.1%671.0%22.9%43.0%1.5%9.1%-13.5%17.6%
EBITDA$-61.86M$-50.11M$-96.26M$-6.47M$-13.13M$1.74M$3.94M$20.62M$23.37M$29.96M$55.17M$81.15M$238.30M$876.12M$56.67M$142.77M$81.20M$100.84M$40.79M$192.74M
EBITDA margin-43.9%-388.6%-352.4%-16.6%-55.8%5.8%12.6%42.1%36.2%41.7%50.6%57.5%94.8%728.4%34.6%59.1%41.4%76.8%24.4%71.9%
EBIT$-78.08M$-52.72M$-97.31M$-9.60M$-15.35M$-1.05M$1.22M$17.96M$20.71M$27.33M$43.88M$68.63M$221.61M$832.38M$28.71M$91.82M$37.81M$64.32M$5.55M$158.96M
Interest expense$10.61M$735000.00$202000.00$270000.00$58000.00$2.51M$3.31M$2.08M$4.86M$11.80M$12.18M$11.40M$48.28M$35.74M$27.41M$19.62M$1.80M$656000.00$3.04M$4.71M
Income tax$-38.41M$-18.70M$-55000.00$-7.92M$-2.62M$-13.10M$-1.19M$374000.00$410000.00$-219.60M$10.33M$44.67M$30.01M$167.34M$-5.31M$-4.15M$41.23M$9.84M$6.55M
Effective tax rate54.8%-7.1%0.1%80.3%17.3%447.7%69.3%3.2%3.3%-582.3%118.8%78.1%17.3%21.0%64.0%-7.8%524.0%15.9%260.1%0.0%
Net income$-31.74M$281.69M$-98.11M$-1.95M$-12.52M$10.18M$-527000.00$11.42M$12.02M$257.31M$-1.64M$12.56M$143.32M$629.30M$-2.98M$57.14M$-33.36M$52.15M$-4.03M$124.45M
Net income growth (YoY)+987.4%-134.8%+98.0%-542.5%+181.3%-105.2%+2267.2%+5.3%+2039.9%-100.6%+867.5%+1041.5%+339.1%-100.5%+2014.2%-158.4%+256.3%-107.7%+3186.6%
Profit margin-22.5%2184.6%-359.2%-5.0%-53.2%33.9%-1.7%23.3%18.6%357.8%-1.5%8.9%57.0%523.2%-1.8%23.7%-17.0%39.7%-2.4%46.4%